ADCY2 anticorps (Middle Region)

N° du produit ABIN928275

Cet anticorps anti-ADCY2 est un anticorps Lapin Polyclonal détectant ADCY2 dans WB. Adapté pour Humain.

Aperçu rapide pour ADCY2 anticorps (Middle Region) (ABIN928275)

Antigène: ADCY2 (Adenylate Cyclase 2 (Brain) (ADCY2))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ADCY2 est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-ADCY2 anticorps

Épitope: Middle Region

Purification: Purified

Immunogène: ADCY2 antibody was raised in rabbit using the middle region of ADCY2 as the immunogen

Information d'application

Indications d'application: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Commentaires:

ADCY2 Blocking Peptide, (ABIN938373), is also available for use as a blocking control in assays to test for specificity of this ADCY2 antibody

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Détails sur ADCY2

Antigène: ADCY2 (Adenylate Cyclase 2 (Brain) (ADCY2))

Autre désignation: ADCY2

Sujet: This gene encodes a member of the family of adenylate cyclases, which are membrane-associated enzymes that catalyze the formation of the secondary messenger cyclic adenosine monophosphate (cAMP). This enzyme is insensitive to Ca(2+)/calmodulin, and is stimulated by the G protein beta and gamma subunit complex. Synonyms: Polyclonal ADCY2 antibody, Anti-ADCY2 antibody, adenylate cyclase 2, brain antibody, AC2 antibody, FLJ16822 antibody, FLJ45092 antibody, HBAC2 antibody, KIAA1060 antibody, MGC133314 antibody.

Pathways: EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Thyroid Hormone Synthesis, cAMP Metabolic Process, Myometrial Relaxation and Contraction, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma